DWTX
NASDAQ
$1.38
Virios Therapeutics Inc (DWTX)
Dogwood Therapeutics, Inc., a development-stage biotechnology company, focuses on developing novel antiviral therapies to treat diseases associated with a viral triggered abnormal immune response. The company is headquartered in Alpharetta, Georgia.
Sector:
Healthcare
Industry:
Biotechnology
Strong Buy
Target: $14 (+914.49%)
Market Cap
$48M
P/B Ratio
0.60
Free Cash Flow Yield
-32.27%
Beta (5Y)
0.92
Price Chart
Valuation
Market Cap$48M
P/B0.60
Profitability
EBITDA-$29M
EPS-$0.58
Financial Health
Free Cash Flow Yield-32.27%
Growth & Risk
FCF 5Y CAGR+12.20%
Beta (5Y)0.92
Sharpe Ratio-0.87